# Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis

> **NCT01437098** · NA · COMPLETED · sponsor: **Medtronic Cardiovascular** · enrollment: 55 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** MDT-2111 CoreValve for TAVI

## Key facts

- **NCT ID:** NCT01437098
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-04
- **Final completion:** 2018-11-27
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437098, "Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01437098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*